Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C J Dunn

Showing results (1-10 of 105) with videos related to

Pageof 11
Sort By:
Agents and Actions|February 1, 1976
Inflammatory mechanisms in the newbornC J Dunn
Drugs|August 10, 2000
Dalteparin: an update of its pharmacological properties and clinical efficacy in the prophylaxis and treatment of thromboembolic diseaseC J Dunn, B Jarvis
Drugs|February 1, 1996
Epoetin beta. A review of its pharmacological properties and clinical use in the management of anaemia associated with chronic renal failureC J Dunn, A Markham
Drugs|October 13, 2000
NateglinideC J Dunn, D Faulds
Drugs|May 23, 2001
Risedronate: a review of its pharmacological properties and clinical use in resorptive bone diseaseC J Dunn, K L Goa
Drugs|April 25, 2000
Lenograstim: an update of its pharmacological properties and use in chemotherapy-induced neutropenia and related clinical settingsC J Dunn, K L Goa
Drugs|July 10, 1999
Tranexamic acid: a review of its use in surgery and other indicationsC J Dunn, K L Goa
Drugs|March 29, 2001
Zafirlukast: an update of its pharmacology and therapeutic efficacy in asthmaC J Dunn, K L Goa
Drugs & Aging|November 1, 1995
Celiprolol. An evaluation of its pharmacological properties and clinical efficacy in the management of hypertension and angina pectorisC J Dunn, C M Spencer
Drugs|August 1, 1996
Dalteparin sodium. A review of its pharmacology and clinical use in the prevention and treatment of thromboembolic disordersC J Dunn, E M Sorkin
Pageof 11

Showing results (1-10 of 105) with videos related to

Sort By:
Pageof 11
Agents and Actions|February 1, 1976
Inflammatory mechanisms in the newbornC J Dunn
Drugs|August 10, 2000
Dalteparin: an update of its pharmacological properties and clinical efficacy in the prophylaxis and treatment of thromboembolic diseaseC J Dunn, B Jarvis
Drugs|February 1, 1996
Epoetin beta. A review of its pharmacological properties and clinical use in the management of anaemia associated with chronic renal failureC J Dunn, A Markham
Drugs|October 13, 2000
NateglinideC J Dunn, D Faulds
Drugs|May 23, 2001
Risedronate: a review of its pharmacological properties and clinical use in resorptive bone diseaseC J Dunn, K L Goa
Drugs|April 25, 2000
Lenograstim: an update of its pharmacological properties and use in chemotherapy-induced neutropenia and related clinical settingsC J Dunn, K L Goa
Drugs|July 10, 1999
Tranexamic acid: a review of its use in surgery and other indicationsC J Dunn, K L Goa
Drugs|March 29, 2001
Zafirlukast: an update of its pharmacology and therapeutic efficacy in asthmaC J Dunn, K L Goa
Drugs & Aging|November 1, 1995
Celiprolol. An evaluation of its pharmacological properties and clinical efficacy in the management of hypertension and angina pectorisC J Dunn, C M Spencer
Drugs|August 1, 1996
Dalteparin sodium. A review of its pharmacology and clinical use in the prevention and treatment of thromboembolic disordersC J Dunn, E M Sorkin
Pageof 11